RT Journal Article
SR Electronic
T1 The mediating role of epigenetic clocks underlying educational inequalities in mortality: a multi-cohort study
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.07.01.21259023
DO 10.1101/2021.07.01.21259023
A1 Giovanni Fiorito
A1 Sara Pedron
A1 Carolina Ochoa-Rosales
A1 Cathal McCrory
A1 Silvia Polidoro
A1 Yan Zhang
A1 Pierre-Antoine Dugué
A1 Scott Ratliff
A1 Wei Zhao
A1 Gareth J McKay
A1 Giuseppe Costa
A1 Maria Giuliana Solinas
A1 Kathleen Mullan Harris
A1 Rosario Tumino
A1 Sara Grioni
A1 Fulvio Ricceri
A1 Salvatore Panico
A1 Hermann Brenner
A1 Lars Schwettmann
A1 Melanie Waldenberger
A1 Pamela R Matias-Garcia
A1 Annette Peters
A1 Allison Hodge
A1 Graham G Giles
A1 Lauren L. Schmitz
A1 Morgan Levine
A1 Jennifer Smith
A1 Yongmei Liu
A1 Frank Kee
A1 Ian Young
A1 Bernadette McGuinness
A1 Amy Jayne McKnight
A1 Joyce van Meurs
A1 Trudy Voortman
A1 Rose A Kenny
A1 Lifepath consortium
A1 Paolo Vineis
A1 Cristian Carmeli
YR 2021
UL http://medrxiv.org/content/early/2021/07/02/2021.07.01.21259023.abstract
AB Educational inequalities in mortality have been observed for decades, however the underlying biological mechanisms are not well known. We assessed the mediating role of altered aging of immune cells functioning captured by DNA methylation changes in blood (known as epigenetic clocks) in educational associated all-cause mortality. Data were from eight prospective population-based cohort studies, representing 13,021 participants. We found educational inequalities in mortality were larger for men than for women, estimated by hazard differences and ratios. Epigenetic clocks explained approximately 50% of educational inequalities in mortality for men, while the proportion was small for women. Most of this mediation was explained by differential effects of unhealthy lifestyles and morbidities of the WHO risk factors for premature mortality. These results support DNA methylation-based epigenetic aging as a signature of educational inequalities in life expectancy emphasizing the need for policies to address the unequal social distribution of these WHO risk factors.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by the European Commission [grant Horizon 2020 number 633666]. Extended acknowledgements for each cohort are reported in Supplementary Material.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Approval from Ethics Committee for each cohort is reported in a table of the Supplementary Material.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesCohort data are available upon request to the PI of each cohort study. Programming code that supports the findings of this study is available from the corresponding author upon request.